While technical limitations prevent the scale and resolution of this system from being transferred to human clinical trials, Johnson and his colleagues are already preparing to publish a paper on normal aging from their study, which will be followed by one on Alzheimer's disease.

They also are looking into funding for a third area of study on the use of dietary changes and drug interventions on these processes, hoping to examine these changes in a population of mice.


Additionally, they are looking with the CHDI Foundation at studying models of Huntington's disease, potentially by July, as well as other collaborators for autism; neurotoxicology, particularly in children; and neurodevelopment and how that trajectory can be altered.

The National Institutes of Health supported the research.

The findings were published in the Proceedings of the National Academy of Sciences.

Correction: An earlier version of this article said that the new imaging method's resolution was 64 times higher than traditional MR scanners. It is actually 64 million times more. HCB News apologizes for the error.

Back to HCB News

MRI Homepage